Labcorp Return on Tangible Equity 2010-2024 | LH

Current and historical return on tangible equity values for Labcorp (LH) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Labcorp Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $0.44B $-1.85B -26.12%
2024-06-30 $0.45B $-1.55B -27.45%
2024-03-31 $0.43B $-1.65B -31.22%
2023-12-31 $0.42B $-1.61B -29.95%
2023-09-30 $0.66B $-1.73B -84.66%
2023-06-30 $0.83B $-0.55B -100.06%
2023-03-31 $1.00B $-1.69B -92.07%
2022-12-31 $1.28B $0.85B -125.52%
2022-09-30 $1.76B $-1.93B -110.69%
2022-06-30 $1.99B $-1.58B -143.42%
2022-03-31 $2.10B $-1.42B -160.60%
2021-12-31 $2.38B $-1.42B -177.92%
2021-09-30 $2.76B $-1.14B -178.22%
2021-06-30 $2.88B $-1.25B -137.75%
2021-03-31 $2.64B $-1.53B -95.67%
2020-12-31 $1.56B $-2.28B -45.13%
2020-09-30 $0.85B $-3.30B -21.33%
2020-06-30 $0.36B $-3.95B -8.46%
2020-03-31 $0.32B $-4.27B -7.16%
2019-12-31 $0.82B $-4.33B -18.50%
2019-09-30 $0.76B $-4.61B -16.99%
2019-06-30 $0.85B $-4.72B -19.75%
2019-03-31 $0.90B $-4.16B -21.11%
2018-12-31 $0.88B $-4.30B -19.90%
2018-09-30 $1.41B $-4.11B -31.02%
2018-06-30 $1.27B $-4.44B -25.67%
2018-03-31 $1.22B $-4.93B -24.74%
2017-12-31 $1.23B $-4.76B -25.74%
2017-09-30 $0.70B $-5.62B -15.11%
2017-06-30 $0.71B $-4.39B -16.42%
2017-03-31 $0.73B $-4.32B -16.97%
2016-12-31 $0.71B $-4.32B -16.37%
2016-09-30 $0.66B $-4.32B -14.90%
2016-06-30 $0.63B $-4.26B -14.02%
2016-03-31 $0.60B $-4.50B -12.74%
2015-12-31 $0.44B $-4.58B -8.90%
2015-09-30 $0.45B $-4.72B -10.63%
2015-06-30 $0.43B $-5.01B -12.36%
2015-03-31 $0.40B $-5.37B -14.76%
2014-12-31 $0.51B $-1.76B -26.88%
2014-09-30 $0.52B $-1.79B -26.01%
2014-06-30 $0.53B $-1.96B -25.77%
2014-03-31 $0.54B $-2.10B -26.41%
2013-12-31 $0.57B $-2.10B -29.30%
2013-09-30 $0.57B $-2.03B -29.96%
2013-06-30 $0.57B $-1.93B -30.75%
2013-03-31 $0.57B $-1.76B -32.01%
2012-12-31 $0.58B $-1.85B -33.15%
2012-09-30 $0.60B $-1.83B -34.26%
2012-06-30 $0.58B $-1.65B -34.15%
2012-03-31 $0.55B $-1.70B -31.98%
2011-12-31 $0.52B $-1.80B -29.16%
2011-09-30 $0.52B $-1.69B -28.95%
2011-06-30 $0.52B $-1.74B -31.70%
2011-03-31 $0.55B $-1.89B -36.82%
2010-12-31 $0.56B $-1.81B -42.56%
2010-09-30 $0.57B $-1.15B -49.80%
2010-06-30 $0.56B $-1.16B -48.79%
2010-03-31 $0.54B $-1.14B -48.94%
2009-12-31 $0.54B $-1.13B -48.69%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.727B $13.009B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.539B 20.67
Becton Dickinson (BDX) United States $65.341B 16.36
Cardinal Health (CAH) United States $30.619B 16.40
Straumann Holding AG (SAUHY) Switzerland $23.663B 0.00
Cooper (COO) United States $17.256B 23.37
Align Technology (ALGN) United States $15.064B 28.62
West Pharmaceutical Services (WST) United States $14.641B 30.00
Henry Schein (HSIC) United States $9.704B 18.49
Merit Medical Systems (MMSI) United States $6.202B 31.67
DENTSPLY SIRONA (XRAY) United States $3.773B 10.26
Patterson (PDCO) United States $2.741B 14.64
CONMED (CNMD) United States $1.948B 15.15
STAAR Surgical (STAA) United States $0.876B 0.00
Lifevantage (LFVN) United States $0.230B 25.50
Pro-Dex (PDEX) United States $0.112B 17.13